Malaguarnera, Mariano · Current opinion in gastroenterology · 2012 · DOI
This review article discusses carnitine and its chemical cousins (acetyl-L-carnitine and propionyl-L-carnitine), which are natural substances your body uses to convert food into energy. The authors explain that these compounds may help with various conditions including chronic fatigue syndrome, depression, memory problems, and heart disease, and appear to be safe with few side effects.
This review identifies acetyl-L-carnitine as a potentially beneficial intervention for ME/CFS specifically, suggesting it may address underlying energy metabolism dysfunction. For ME/CFS patients, understanding carnitine's role in cellular energy production and its potential neuroprotective effects provides a biochemical rationale for why supplementation might merit further investigation.
This review does not establish efficacy—it summarizes existing literature without presenting new clinical trial data or controlled evidence. The mention of ME/CFS benefit reflects previous research rather than proof that carnitine supplementation actually improves outcomes in ME/CFS patients. This article cannot determine optimal dosing, which patient populations would benefit most, or whether benefits outweigh costs.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →